XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (UNAUDITED) - USD ($)
$ in Thousands
Total
Total Charles River Laboratories, Inc. Equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance at Dec. 31, 2022 $ 42,427              
Increase (Decrease) in Temporary Equity                
Net income 322              
Other comprehensive (loss), net of tax 186              
Ending balance at Apr. 01, 2023 42,935              
Beginning balance (in shares) at Dec. 31, 2022     50,944,000          
Beginning balance at Dec. 31, 2022 2,981,078 $ 2,976,293 $ 509 $ 1,804,940 $ 1,432,901 $ (262,057) $ 0 $ 4,785
Beginning balance (in shares) at Dec. 31, 2022             0  
Increase (Decrease) in Stockholders' Equity                
Net income 103,632 103,131     103,131     501
Other comprehensive (loss), net of tax 22,933 22,933       22,933    
Issuance of stock under employee compensation plans (in shares)     316,000          
Issuance of stock under employee compensation plans 11,792 11,792 $ 3 11,789        
Purchase of treasury shares (in shares)             78,000  
Purchase of treasury shares (19,012) (19,012)         $ (19,012)  
Stock-based compensation 13,460 13,460   13,460        
Ending balance (in shares) at Apr. 01, 2023     51,260,000          
Ending balance at Apr. 01, 2023 3,113,883 3,108,597 $ 512 1,830,189 1,536,032 (239,124) $ (19,012) 5,286
Ending balance (in shares) at Apr. 01, 2023             78,000  
Increase (Decrease) in Temporary Equity                
Net income 1,857              
Other comprehensive (loss), net of tax (2,345)              
Ending balance at Jul. 01, 2023 42,447              
Increase (Decrease) in Stockholders' Equity                
Net income 97,586 97,020     97,020     566
Other comprehensive (loss), net of tax 30,855 30,855       30,855    
Issuance of stock under employee compensation plans (in shares)     110,000          
Issuance of stock under employee compensation plans 3,927 3,927 $ 1 3,926        
Purchase of treasury shares (in shares)             26,000  
Purchase of treasury shares (4,966) (4,966)         $ (4,966)  
Stock-based compensation 16,270 16,270   16,270        
Ending balance (in shares) at Jul. 01, 2023     51,370,000          
Ending balance at Jul. 01, 2023 3,257,555 3,251,703 $ 513 1,850,385 1,633,052 (208,269) $ (23,978) 5,852
Ending balance (in shares) at Jul. 01, 2023             104,000  
Increase (Decrease) in Temporary Equity                
Net income 71              
Other comprehensive (loss), net of tax (192)              
Dividends to noncontrolling interests (2,378)              
Ending balance at Sep. 30, 2023 39,948              
Increase (Decrease) in Stockholders' Equity                
Net income 87,950 87,389     87,389     561
Other comprehensive (loss), net of tax (59,797) (59,797)       (59,797)    
Dividends to noncontrolling interests (1,645)             (1,645)
Issuance of stock under employee compensation plans (in shares)     30,000          
Issuance of stock under employee compensation plans 3,939 3,939 $ 1 3,938        
Purchase of treasury shares (38) (38)         $ (38)  
Stock-based compensation 22,797 22,797   22,797        
Ending balance (in shares) at Sep. 30, 2023     51,400,000          
Ending balance at Sep. 30, 2023 3,310,761 3,305,993 $ 514 1,877,120 1,720,441 (268,066) $ (24,016) 4,768
Ending balance (in shares) at Sep. 30, 2023             104,000  
Beginning balance at Dec. 30, 2023 56,722              
Increase (Decrease) in Temporary Equity                
Net income 1,201              
Other comprehensive (loss), net of tax (2,763)              
Adjustment of redeemable noncontrolling interests to redemption value 4,807              
Dividends to noncontrolling interests (2,192)              
Ending balance at Mar. 30, 2024 $ 57,775              
Beginning balance (in shares) at Dec. 30, 2023 51,338,000   51,338,000          
Beginning balance at Dec. 30, 2023 $ 3,602,276 3,596,882 $ 513 1,905,578 1,887,218 (196,427) $ 0 5,394
Beginning balance (in shares) at Dec. 30, 2023 0           0  
Increase (Decrease) in Stockholders' Equity                
Net income $ 73,281 72,960     72,960     321
Other comprehensive (loss), net of tax (53,492) (53,492)       (53,492)    
Adjustment of redeemable noncontrolling interests to redemption value (4,807) (4,807)   (4,406) (401)      
Issuance of stock under employee compensation plans (in shares)     214,000          
Issuance of stock under employee compensation plans 21,505 21,505 $ 2 21,503        
Purchase of treasury shares (in shares)             42,000  
Purchase of treasury shares (9,351) (9,351)         $ (9,351)  
Stock-based compensation 16,738 16,738   16,738        
Ending balance (in shares) at Mar. 30, 2024     51,552,000          
Ending balance at Mar. 30, 2024 3,646,150 3,640,435 $ 515 1,939,413 1,959,777 (249,919) $ (9,351) 5,715
Ending balance (in shares) at Mar. 30, 2024             42,000  
Beginning balance at Dec. 30, 2023 56,722              
Ending balance at Sep. 28, 2024 $ 40,590              
Beginning balance (in shares) at Dec. 30, 2023 51,338,000   51,338,000          
Beginning balance at Dec. 30, 2023 $ 3,602,276 3,596,882 $ 513 1,905,578 1,887,218 (196,427) $ 0 5,394
Beginning balance (in shares) at Dec. 30, 2023 0           0  
Ending balance (in shares) at Sep. 28, 2024 51,134,000   51,718,000          
Ending balance at Sep. 28, 2024 $ 3,787,127 3,782,273 $ 517 1,971,413 2,122,835 (192,871) $ (119,621) 4,854
Ending balance (in shares) at Sep. 28, 2024 584,000           584,000  
Beginning balance at Mar. 30, 2024 $ 57,775              
Increase (Decrease) in Temporary Equity                
Net income (332)              
Other comprehensive (loss), net of tax 85              
Adjustment of redeemable noncontrolling interests to redemption value 496              
Purchase of remaining equity interest of other redeemable noncontrolling interest (12,000)              
Adjustment of purchase price of Noveprim redeemable noncontrolling interest 52              
Ending balance at Jun. 29, 2024 46,076              
Beginning balance (in shares) at Mar. 30, 2024     51,552,000          
Beginning balance at Mar. 30, 2024 3,646,150 3,640,435 $ 515 1,939,413 1,959,777 (249,919) $ (9,351) 5,715
Beginning balance (in shares) at Mar. 30, 2024             42,000  
Increase (Decrease) in Stockholders' Equity                
Net income 94,593 94,081     94,081     512
Other comprehensive (loss), net of tax (19,790) (19,790)       (19,790)    
Adjustment of redeemable noncontrolling interests to redemption value (496) (496)   (195) (301)      
Dividends to noncontrolling interests (1,938)             (1,938)
Issuance of stock under employee compensation plans (in shares)     144,000          
Issuance of stock under employee compensation plans 826 826 $ 2 824        
Purchase of treasury shares (in shares)             41,000  
Purchase of treasury shares (8,914) (8,914)         $ (8,914)  
Stock-based compensation 16,587 16,587   16,587        
Ending balance (in shares) at Jun. 29, 2024     51,696,000          
Ending balance at Jun. 29, 2024 3,727,018 3,722,729 $ 517 1,956,629 2,053,557 (269,709) $ (18,265) 4,289
Ending balance (in shares) at Jun. 29, 2024             83,000  
Increase (Decrease) in Temporary Equity                
Net income 73              
Other comprehensive (loss), net of tax (876)              
Adjustment of redeemable noncontrolling interests to redemption value 5,705              
Dividends to noncontrolling interests (10,388)              
Ending balance at Sep. 28, 2024 40,590              
Increase (Decrease) in Stockholders' Equity                
Net income 70,222 69,657     69,657     565
Other comprehensive (loss), net of tax 76,838 76,838       76,838    
Adjustment of redeemable noncontrolling interests to redemption value (5,705) (5,705)   (5,326) (379)      
Issuance of stock under employee compensation plans (in shares)     22,000          
Issuance of stock under employee compensation plans 779 779   779        
Purchase of treasury shares (in shares)             501,000  
Purchase of treasury shares (100,786) (100,786)         $ (100,786)  
Share repurchase excise tax (570) (570)         (570)  
Stock-based compensation $ 19,331 19,331   19,331        
Ending balance (in shares) at Sep. 28, 2024 51,134,000   51,718,000          
Ending balance at Sep. 28, 2024 $ 3,787,127 $ 3,782,273 $ 517 $ 1,971,413 $ 2,122,835 $ (192,871) $ (119,621) $ 4,854
Ending balance (in shares) at Sep. 28, 2024 584,000           584,000